Roche Continues To Cast Its Collaborations Net Wide
Partnering Chief James Sabry Speaks To Scrip
The Swiss major gets around 3,000 proposals per year and has assembled a 120-strong team to sift through them and access the best science out there. Global head of pharma partnering James Sabry tells Scrip what Roche is looking for in a partner.
You may also be interested in...
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: GSK deal strengthens its infectious disease pipeline; an analysis of the first drugs subject to US Medicare price negotiations; Roche partnering head talks about strategy; promising early Alzheimer’s results for Biogen’s tau drug; and what India needs to become a world-class innovation hub.
Deal Watch: Japan’s JCR Inks Pacts With Sumitomo Dainippon, Alexion
Agreement with Alexion is JCR’s first international deal for its blood-brain barrier drug delivery technology. Sartoris buys PolyPlus from private equity investors.
Genentech Licenses Prostate Cancer Drug From China-Based Jemincare
Deal Snapshot: Other major players have made headway in bispecifics for prostate cancer, while Jemincare’s drug is the latest China-developed technology to head westward.